Brigit Biofarmaka Teknologi Tbk. vs Widiant Jaya Krenindo Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Widiant Jaya Krenindo Tbk. trades at Rp30 (market cap 44.8B, 34.83M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 3.9× Widiant Jaya Krenindo Tbk.'s market cap, and Widiant Jaya Krenindo Tbk. is more actively traded (34.83M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | WIDI | |
|---|---|---|
Market Cap | 172.82B | 44.8B |
Volume | 592.2K | 34.83M |
Lot | 5.92K | 348.28K |
Turnover | 147.05M | 1.04B |
Average Price | 248.31 | 29.73 |
Value | 147.05M | 1.04B |
Indicative Equilibrium Price | 254 | 30 |
Indicative Equilibrium Volume | 10 | 5 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Widiant Jaya Krenindo Tbk (the Company) was established based on Notarial Deed No. 2 of Ruping Lolo Alias Vince, S.H., Notary in Karawang, dated August 13, 2016. The Company begin their operation activities in 2016.
Read more on WIDI →